PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN. (23rd June 2022) - Pemmaraju, N.; Martinelli, G.; Todisco, E.; Tarella, C.; Montesinos, P.; Lane, A. A.; Erba, H. P.; Sweet, K. L.; Walter, R. B.; Deconinck, E.; Wang, E. S.; Aribi, A.; et al.